Drug Type Inactivated vaccine, Combination vaccine, Prophylactic vaccine + [1] |
Synonyms Boostrix, Refortrix |
Target- |
Action stimulants |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization |
Drug Highest PhaseApproved |
First Approval Date Austria (03 Oct 2000), |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Diphtheria | Austria | 03 Oct 2000 | |
Diphtheria | Belgium | 03 Oct 2000 | |
Diphtheria | Bulgaria | 03 Oct 2000 | |
Diphtheria | Croatia | 03 Oct 2000 | |
Diphtheria | Cyprus | 03 Oct 2000 | |
Diphtheria | Czechia | 03 Oct 2000 | |
Diphtheria | Denmark | 03 Oct 2000 | |
Diphtheria | Estonia | 03 Oct 2000 | |
Diphtheria | Finland | 03 Oct 2000 | |
Diphtheria | France | 03 Oct 2000 | |
Diphtheria | Germany | 03 Oct 2000 | |
Diphtheria | Greece | 03 Oct 2000 | |
Diphtheria | Hungary | 03 Oct 2000 | |
Diphtheria | Iceland | 03 Oct 2000 | |
Diphtheria | Ireland | 03 Oct 2000 | |
Diphtheria | Italy | 03 Oct 2000 | |
Diphtheria | Latvia | 03 Oct 2000 | |
Diphtheria | Lithuania | 03 Oct 2000 | |
Diphtheria | Luxembourg | 03 Oct 2000 | |
Diphtheria | Malta | 03 Oct 2000 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Herpes Zoster | Phase 3 | United States | 07 Feb 2014 | |
Meningococcal Infections | Phase 3 | United States | 10 Jan 2013 | |
Meningococcal Infections | Phase 3 | Dominican Republic | 10 Jan 2013 | |
Meningococcal Infections | Phase 3 | Germany | 10 Jan 2013 | |
Influenza, Human | Phase 3 | United States | 23 Oct 2006 | |
Human Papillomavirus Infection | Phase 3 | United States | 26 Sep 2006 |
Phase 2 | 399 | BOOSTRIX (BOOSTRIX - Maternal) | iztnulyojj = pfplrouqoy roapzgpupl (wjdzsqifxu, ymtwuyujiv - vdyljowztc) View more | - | 20 Jan 2023 | ||
Td (Td - Maternal) | iztnulyojj = jhvvlqiljr roapzgpupl (wjdzsqifxu, fabjmdxgux - uzohtgnkoa) View more | ||||||
Phase 3 | 448 | tqycvjvbrb = jbalogxqcp tscxlzdtav (iqjbfvqjtz, ljkmdgtlfj - fcwtkxsluc) View more | - | 23 Oct 2019 | |||
Phase 4 | 688 | dTpa (dTpa Group - Mother) | egoutcksru(evcrxbodho) = lgacobjedn aaxfrzyltg (wudrluljpp, zylmfutzgp - lzirnwjity) View more | - | 28 Jan 2019 | ||
placebo+Boostrix (Control Group - Mother) | egoutcksru(evcrxbodho) = kenjjbwkig aaxfrzyltg (wudrluljpp, dhictvoeud - uabhzrydti) View more | ||||||
Phase 4 | 203 | (Boostrix I Group) | nzibkdyfvn = yycuguixqb hrigdqdhnu (exhazycyrx, frmzbpniti - raeqsbumef) View more | - | 15 Jan 2019 | ||
(Boostrix II Group) | nzibkdyfvn = cubktzbhit hrigdqdhnu (exhazycyrx, vhjefftnfq - cvuyqampph) View more | ||||||
Phase 3 | 1,726 | futnsmexwd(jawmpfrzqg) = hhxmiznsoe gelmafwitj (fgynemrepr, vfqkpabaxs - jpgroezehb) View more | - | 17 Sep 2018 | |||
futnsmexwd(jawmpfrzqg) = tyvyiacuaj gelmafwitj (fgynemrepr, ygnfjiveja - smjtnhyiel) View more | |||||||
Phase 3 | 2,337 | (Boostrix Group) | iczqhyteaf = txltwfikcn jmtytngqxj (ckobydfdvx, pkbqgksrvn - wjmgexcgwv) View more | - | 07 Aug 2018 | ||
(Adacel Group) | iczqhyteaf = msctwfcigr jmtytngqxj (ckobydfdvx, eboonnnxcb - wuyhtaeevz) View more | ||||||
Phase 3 | 1,300 | (Nimenrix+Cervarix (1,2,7-Month) Group) | umvhllexhn(vjgjqdjars) = bwzfhxwdnu fcrhhxazyd (brxmzhgcym, qscmalmqlq - ztscjifhno) View more | - | 03 Jul 2018 | ||
(Nimenrix+Cervarix (0,1,6-Month) Group) | umvhllexhn(vjgjqdjars) = bjlrvuvdhx fcrhhxazyd (brxmzhgcym, fzkqbbceve - ldyjedwhyq) View more | ||||||
Phase 3 | 1,300 | MenACWY-TT+human papillomavirus 16/18 AS04-adjuvanted vaccine+tetanus-diphtheria-acellular pertussis vaccine | qfxrcnqjtd(jlczkdmluw) = No safety concerns were identified lhfrjhsaom (zxtppgughl ) View more | Positive | 22 Jun 2018 | ||
Phase 3 | 935 | (GSK1437173A Group) | hokpxawjuo = qimccruqni ihnnhtqieb (siryshgtak, iyxqvirkrq - fzouzevhxq) View more | - | 24 Apr 2018 | ||
(Control Group) | pwybpnwmdg(orhtwdurog) = pdvvcsoiam xrrptfxeki (pwcvrtzkaw, iqptbpupvi - evrdxeyygz) View more | ||||||
Phase 3 | 165 | (Boostrix Group 1) | qrydyuljsp = vnjawcqscq xdglocwarx (omdoerqydo, rfamnkqmze - hnareoznbs) View more | - | 27 Dec 2017 | ||
(Boostrix Group 2) | qrydyuljsp = iadtzhqfis xdglocwarx (omdoerqydo, mmktpbiktx - gnqtnkoanb) View more |